United States · FDA National Drug Code directory
TicoVac
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0411_73c064c0-c613-4c05-85c5-37ef233827ee
- Product NDC
- 0069-0411
- Form
- INJECTION
- Composition / generic term
- Tick-Borne Encephalitis Vaccine
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20211025
- Source listing expiry
- 20271231
Source-listed ingredients
- TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED) — 2.4 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0069-0411-02) / .5 mL in 1 SYRINGE (0069-0411-01) · 0069-0411-02
- 10 SYRINGE in 1 CARTON (0069-0411-10) / .5 mL in 1 SYRINGE (0069-0411-01) · 0069-0411-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →